A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

The market offers significant opportunities in non-invasive cancer diagnostics using in vitro blood tests, with potential to replace traditional biopsies. Key areas include screening, diagnosis, ...

Natera has acquired Foresight Diagnostics, a business known for its ultrasensitive MRD detection, in an all-stock transaction ...

A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Natera ( (NTRA) ) just unveiled an update.

In the largest ever study of the nasal microbiome, researchers have discovered that persistent carriers of Staphylococcus ...

At the meeting, researchers shared real-world data showing ctDNA positivity at the end of treatment was prognostic across lymphoma subtypes and better than PET scans.

Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress ...

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial ...

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with ...